RM新时代新项目,RM新时代投资官网|首入球时间

In the current field of animal disease prevention and control, the immunodiagnosis process often encounters the problem of "shortage" of diagnostic raw materials:

? The antibodies are not highly specific and are prone to cross-react with other pathogens, resulting in "false positive" misjudgments;

? The sensitivity is insufficient, making it difficult to detect trace amounts of pathogens in the early stage, thus missing the best prevention and control opportunity;

? There is a lack of suitable diagnostic raw materials for new and variant strains;

? Some antibodies have poor stability and require high-cost storage and transportation at low temperatures, making them inconvenient for use at the grassroots level.

Shanghai Xiongtu relies on the pathogen molecular biology laboratories, monoclonal antibody preparation platforms and high-level talent teams of universities and research institutes, and combines the market demands collected by the company over the years of serving the industry to form a "basic research - technology transformation - market application" closed loop. Its research advantages directly address the industry's pain points, enabling animal disease diagnosis to truly achieve "fast, accurate, stable and cost-effective"!

The currently developed products have the following features:

·? High specificity: Accurate identification, zero cross-reaction

·? High sensitivity: Early detection and prevention, blocking the transmission chain

·? High stability: Suitable for multiple scenarios, reducing usage costs

RM新时代官网-首页